(a) - (c) On November 22, 2022, Fund and Fund II entered into a Loan and Security Agreement, and related agreements (collectively, the "Agreement"), by and among Issuer, as borrower, Fund and Fund II, as lenders, and Manager, as administrative agent and collateral agent, pursuant to which lenders agreed to fund an initial Growth Capital Loan (as defined in the Agreement) in the aggregate original principal amount of $10,000,000. As consideration for the commitment, lenders received an equity grant equal to 547,807 shares of Issuer's common stock. Effective as of Issuer's one-for-eighty reverse stock split on January 31, 2025, the number of such shares was reduced to 6,847 shares. Lenders initially had the right to convert up to $5 million of principal into common stock of Issuer at a conversion price of $2.148. On February 21, 2025, pursuant to a Second Amendment to the Supplement to the Agreement, at any time on or after April 1, 2025, lenders acquired the right to convert up to $10 million of principal at $1.68 per share. The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the common stock in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as they may deem appropriate in light of the circumstances existing from time to time, which may include disposal of some or all of the shares of common stock currently owned by the Reporting Persons or otherwise acquired by them pursuant to conversion of debt or in privately negotiated transactions. Any such transactions may be effected at any time or from time to time subject to any applicable limitations imposed on the sale of the common stock by applicable law. Except to the extent the foregoing may be deemed a plan or proposal, the Reporting Persons have no additional plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.